Adverum Biotechnologies Inc (ADVM)
7.25
-0.31
(-4.10%)
USD |
NASDAQ |
Nov 14, 16:00
7.255
0.00 (0.00%)
After-Hours: 20:00
Adverum Biotechnologies Total Return Level: 7.25 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 7.25 |
November 13, 2024 | 7.56 |
November 12, 2024 | 7.89 |
November 11, 2024 | 7.76 |
November 08, 2024 | 8.00 |
November 07, 2024 | 7.90 |
November 06, 2024 | 7.94 |
November 05, 2024 | 7.72 |
November 04, 2024 | 7.54 |
November 01, 2024 | 7.41 |
October 31, 2024 | 7.295 |
October 30, 2024 | 7.88 |
October 29, 2024 | 7.76 |
October 28, 2024 | 7.92 |
October 25, 2024 | 7.98 |
October 24, 2024 | 8.08 |
October 23, 2024 | 8.12 |
October 22, 2024 | 8.14 |
October 21, 2024 | 8.26 |
October 18, 2024 | 8.48 |
October 17, 2024 | 8.08 |
October 16, 2024 | 8.21 |
October 15, 2024 | 7.69 |
October 14, 2024 | 7.73 |
October 11, 2024 | 7.65 |
Date | Value |
---|---|
October 10, 2024 | 7.44 |
October 09, 2024 | 7.52 |
October 08, 2024 | 7.61 |
October 07, 2024 | 7.44 |
October 04, 2024 | 7.53 |
October 03, 2024 | 7.28 |
October 02, 2024 | 6.82 |
October 01, 2024 | 6.59 |
September 30, 2024 | 7.02 |
September 27, 2024 | 6.94 |
September 26, 2024 | 6.61 |
September 25, 2024 | 6.59 |
September 24, 2024 | 6.94 |
September 23, 2024 | 6.88 |
September 20, 2024 | 7.49 |
September 19, 2024 | 7.50 |
September 18, 2024 | 6.99 |
September 17, 2024 | 7.30 |
September 16, 2024 | 7.21 |
September 13, 2024 | 7.23 |
September 12, 2024 | 7.05 |
September 11, 2024 | 7.03 |
September 10, 2024 | 7.18 |
September 09, 2024 | 6.96 |
September 06, 2024 | 6.76 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
5.40
Minimum
Dec 27 2022
256.40
Maximum
Jun 23 2020
48.30
Average
16.25
Median
Total Return Level Benchmarks
EyePoint Pharmaceuticals Inc | 10.49 |
Cassava Sciences Inc | 44.19 |
Regenxbio Inc | 11.14 |
Editas Medicine Inc | 2.77 |
Apellis Pharmaceuticals Inc | 28.06 |